ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Intervention Psychosis and Addiction (KLIPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01411566
Recruitment Status : Unknown
Verified February 2011 by University of Cologne.
Recruitment status was:  Recruiting
First Posted : August 8, 2011
Last Update Posted : August 8, 2011
Sponsor:
Information provided by:
University of Cologne

Brief Summary:
The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.

Condition or disease Intervention/treatment Phase
Psychosis Substance Abuse Behavioral: Skills trainig for patients with dual diagnosis Behavioral: regular treatment Early Phase 1

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 122 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder
Study Start Date : January 2011
Estimated Primary Completion Date : November 2011
Estimated Study Completion Date : December 2011

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Treatment Behavioral: Skills trainig for patients with dual diagnosis
Skills trainig for patients with dual diagnosis

Active Comparator: Control Behavioral: regular treatment
regular treatment




Primary Outcome Measures :
  1. Substance use [ Time Frame: one year ]
  2. Substance use [ Time Frame: 3 months ]
  3. Substance use [ Time Frame: 6 months ]
  4. Change in drug use motivation [ Time Frame: 3 months ]
  5. Change in drug use motivation [ Time Frame: 6 months ]
  6. Change in drug use motivation [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Schizophrenia
  • Addiction
  • Written statement of agreement
  • Majority

Exclusion Criteria:

  • Acute psychosis
  • Further neuropsychiatric disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01411566


Locations
Germany
LVR Clinic Cologne - Academic Clinic of the University of Cologne Recruiting
Cologne, Germany, 51109
Contact: Joerg Daumann, PhD    +49 221 478 ext 87113    joerg.daumann@uk-koeln.de   
Sub-Investigator: Susanne Koenig, Diploma         
Sponsors and Collaborators
University of Cologne
Investigators
Study Chair: Joerg Daumann, PhD University of Cologne

Responsible Party: Dr. Joerg Daumann, PhD, University of Cologne
ClinicalTrials.gov Identifier: NCT01411566     History of Changes
Other Study ID Numbers: Koeln-Fortune 104/2010
First Posted: August 8, 2011    Key Record Dates
Last Update Posted: August 8, 2011
Last Verified: February 2011

Keywords provided by University of Cologne:
KLIPS

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Substance-Related Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Chemically-Induced Disorders